Analyst Ratings for Monopar Therapeutics (MNPR)

MNPR Rating Summary

MNPR Price Target Summary

* Over Last 12-Mos
  |   Expand Research on MNPR
Overall Rating: BUY   Rating Trend: Up   Avg. $ Target: $33.33 (+531.3%) * Over Last 12-Mos
Rating Score: 10 / 10   Percentile Rank: 95%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
1/28/2021 Roth Capital Elemer Piros New Coverage Buy
(N/A)
49.00
(N/A)
6.81
(5.28)
-22.47% Details
9/24/2020 Maxim Group N/A New Coverage Buy
(N/A)
11.00
(N/A)
4.98
(5.28)
6.02% Details
Like MNPR Ratings? Also take a look at GIS, ZGNX, PRGS, OXM

MNPR Ratings News